Applications across neuroscience and clinical medicine define the value of the
Cortical Electrode Market. Neuroprosthetics represents the largest application segment, valued at $900 million in 2024 and projected to reach $1.7 billion by 2035. These devices restore lost sensory or motor functions by interfacing directly with the nervous system, dramatically improving quality of life for patients with disabilities.
Brain mapping is another critical application, growing from $700 million in 2024 to an anticipated $1.4 billion by 2035. It helps researchers and clinicians understand functional brain architecture, guiding surgical planning and treatment strategies. Seizure monitoring supports early detection and management of epilepsy, while research applications continue to drive foundational discoveries in neuroscience.
The versatility of cortical electrodes ensures sustained demand across hospitals, diagnostic laboratories, and academic institutions. As neurotechnology converges with personalized medicine, tailored electrode solutions are expected to unlock new therapeutic possibilities.
FAQ
Q1: What is the largest application segment? A: Neuroprosthetics is the largest segment, valued at $900 million in 2024.
Q2: How is brain mapping used clinically? A: It guides surgical planning and helps understand brain function before intervention.
Q3: What role do cortical electrodes play in epilepsy? A: They enable real-time seizure monitoring and early detection for better management.
About SPORTIVO Network
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek